Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Miki T, Mizutani Y, Akaza H, Ozono S, Tsukamoto T, Terachi T, Naito K, Nonomura N, Hara I, Yoshida O; Japan Blood Cell Transplantation Study Group for Testicular Germ Cell Tumor. Miki T, et al. Among authors: tsukamoto t. Int J Urol. 2007 Jan;14(1):54-9. doi: 10.1111/j.1442-2042.2006.01655.x. Int J Urol. 2007. PMID: 17199861 Clinical Trial.
Combined immunotherapy with low-dose IL-2 plus IFN-alpha for metastatic renal cell carcinoma: survival benefit for selected patients with lung metastasis and serum sodium level.
Akaza H, Tsukamoto T, Fujioka T, Tomita Y, Kitamura T, Ozono S, Miki T, Naito S, Zembutsu H, Nakamura Y. Akaza H, et al. Among authors: tsukamoto t. Jpn J Clin Oncol. 2011 Aug;41(8):1023-30. doi: 10.1093/jjco/hyr067. Epub 2011 Jun 4. Jpn J Clin Oncol. 2011. PMID: 21642665 Clinical Trial.
The efficacy and safety of degarelix, a GnRH antagonist: a 12-month, multicentre, randomized, maintenance dose-finding phase II study in Japanese patients with prostate cancer.
Ozono S, Ueda T, Hoshi S, Yamaguchi A, Maeda H, Fukuyama Y, Takeda K, Ohashi Y, Tsukamoto T, Naito S, Akaza H. Ozono S, et al. Among authors: tsukamoto t. Jpn J Clin Oncol. 2012 Jun;42(6):477-84. doi: 10.1093/jjco/hys035. Epub 2012 Mar 28. Jpn J Clin Oncol. 2012. PMID: 22457321 Clinical Trial.
Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis.
Kinouchi T, Sakamoto J, Tsukamoto T, Akaza H, Kubota Y, Ozono S, Kanetake H, Taguchi T, Kotake T; Immunotherapy Oncology Group for Renal Cell Carcinoma. Kinouchi T, et al. Among authors: tsukamoto t. J Cancer Res Clin Oncol. 2006 Aug;132(8):499-504. doi: 10.1007/s00432-006-0095-7. Epub 2006 Apr 4. J Cancer Res Clin Oncol. 2006. PMID: 16586071 Clinical Trial.
2,310 results